D
84.51
-0.32 (-0.38%)
| Previous Close | 84.83 |
| Open | 83.94 |
| Volume | 2,325,130 |
| Avg. Volume (3M) | 4,408,509 |
| Market Cap | 33,136,963,584 |
| Price / Earnings (TTM) | 63.54 |
| Price / Earnings (Forward) | 41.32 |
| Price / Sales | 8.21 |
| Price / Book | 14.35 |
| 52 Weeks Range | |
| Earnings Date | 23 Jul 2025 - 28 Jul 2025 |
| Profit Margin | 12.90% |
| Operating Margin (TTM) | 12.91% |
| Diluted EPS (TTM) | 1.33 |
| Quarterly Revenue Growth (YOY) | 12.50% |
| Quarterly Earnings Growth (YOY) | -28.00% |
| Total Debt/Equity (MRQ) | 113.97% |
| Current Ratio (MRQ) | 1.50 |
| Operating Cash Flow (TTM) | 964.10 M |
| Levered Free Cash Flow (TTM) | 509.04 M |
| Return on Assets (TTM) | 5.97% |
| Return on Equity (TTM) | 23.72% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Bearish |
| Medical Devices (Global) | Bearish | Bearish | |
| Stock | DexCom, Inc. | Bearish | Bearish |
AIStockmoo Score
-0.5
| Analyst Consensus | 2.0 |
| Insider Activity | -1.5 |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.0 |
| Average | -0.50 |
|
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Mid Growth |
| % Held by Insiders | 0.42% |
| % Held by Institutions | 97.10% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 106.00 (Canaccord Genuity, 25.43%) | Buy |
| Median | 102.00 (20.70%) | |
| Low | 85.00 (Mizuho, 0.58%) | Buy |
| Average | 98.38 (16.41%) | |
| Total | 7 Buy, 1 Hold | |
| Avg. Price @ Call | 80.76 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Truist Securities | 16 Jun 2025 | 102.00 (20.70%) | Buy | 83.00 |
| Goldman Sachs | 30 May 2025 | 104.00 (23.06%) | Buy | 85.80 |
| Citigroup | 22 May 2025 | 102.00 (20.70%) | Buy | 84.83 |
| Barclays | 05 May 2025 | 93.00 (10.05%) | Hold | 80.27 |
| Baird | 02 May 2025 | 105.00 (24.25%) | Buy | 81.62 |
| Canaccord Genuity | 02 May 2025 | 106.00 (25.43%) | Buy | 81.62 |
| Piper Sandler | 02 May 2025 | 90.00 (6.50%) | Buy | 81.62 |
| Mizuho | 10 Apr 2025 | 85.00 (0.58%) | Buy | 67.30 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| STERN SADIE | - | 85.04 | -1,466 | -124,669 |
| Aggregate Net Quantity | -1,466 | |||
| Aggregate Net Value ($) | -124,669 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 85.04 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| STERN SADIE | Officer | 26 Jun 2025 | Automatic sell (-) | 1,466 | 85.04 | 124,669 |
| Date | Type | Details |
|---|---|---|
| 01 Jul 2025 | Announcement | Dexcom Schedules Second Quarter 2025 Earnings Release and Conference Call for July 30, 2025 at 4:30 p.m. Eastern Time. |
| 18 Jun 2025 | Announcement | Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025 |
| 13 May 2025 | Announcement | Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO |
| 01 May 2025 | Announcement | Dexcom Reports First Quarter 2025 Financial Results and Announces $750 Million Share Repurchase Program |
| 22 Apr 2025 | Announcement | Dexcom Launches First Nationwide Search for College Athletes With Diabetes to Join Season Four of Dexcom U |
| 10 Apr 2025 | Announcement | Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |